Dr. Belafsky's primary clinical interests are the comprehensive diagnosis and management of voice, swallowing, and airway disorders. As medical director of the Voice and Swallowing Center at UC Davis, Dr. Belafsky treats a wide array of laryngeal and esophageal disorders.

Dr. Belafsky has pioneered minimally invasive treatments of voice and swallowing disorders. Minimally invasive in-office procedures he performs at the center include unsedated treatment of laryngeal polyps, leukoplakia, and papillomas, subglottic, tracheal, and esophageal strictures, and office-based vocal fold medialization.

Marthe Haverkamp is a Senior Associate with Alvarez & Marsal’s Healthcare Industry Group in New York. She is a healthcare expert in policy, services, and practice, with a deep understanding of healthcare systems in the US and internationally. Dr. Haverkamp combines strong analytic skills with operational expertise. As a frontline physician leader, she draws from more than 15 years of experience throughout the healthcare sector as a clinician in hospitals, healthcare policy thinktanks, academia and the private sector to come up with cross-fertilized strategies and out-of-the-box solutions.

Prior to joining A&M, Dr. Haverkamp helped start-up companies in both pharma and healthcare-delivery to develop and fund their novel preventive/therapeutic products and ideas. Previously, she was a Fellow in Healthcare, Policy & Practice at the Commonwealth Fund in New York and the Harvard T.H. Chan School of Public Health where she worked with healthcare economists on value-based healthcare and cost-reduction strategies. This research resulted in publications in the BMJ quality&safety and the American Journal of Managed Care. Consequently, she was awarded the Leadership Foundation Fellowship (2017-2018) by the International Women’s Forum, an organization of accomplished women, predominantly from the US corporate sector.

Dr. Haverkamp started her career as an Infectious Disease specialist in the Leiden University Medical Center in the Netherlands. In parallel to her work as a clinical specialist, she served as a strategic advisor to the Dutch government as a member of the Council for Public Health and Healthcare (2012-2015).

Dr. Hovell holds a PhD in Child Psychology and Human Development with specialization in adolescent development from the University of Kansas and a postdoctoral MPH in Social Epidemiology from the University of California at Berkeley. Dr. Hovell is the former and founding Head of the Division of Health Promotion.

Jonathan Kolstad is an Associate Professor of Economic Analysis and Policy at Berkeley Haas and a Research Associate at the National Bureau of Economic Research. He is also the Co-director of the Health Initiative at the UC Berkeley Opportunity Lab.

He is an economist whose research interests lie at the intersection of health economics, industrial organization, and public economics. He is particularly interested in finding new models and unique data that can account for the complexity of markets in health care, notably the role of information asymmetries and incentives. He has studied the impact of quality information on demand, as well as intrinsic surgeon incentives. In a series of papers, he has evaluated the impact of the Massachusetts health insurance expansion on a variety of outcomes. He has also gathered unique data to understand the role of information frictions in consumer decision making in insurance markets and on medical treatments.

Kolstad was awarded the Arrow Award from the International Health Economics Association for the best paper in health economics in 2014 and the NIHCM Foundation Research Award in 2016. He is also a Co-founder and was Chief Data Scientist at Picwell. He received his PhD from Harvard University and BA from Stanford University.

Dr. Lisa Saiman is currently a Professor of Pediatrics and has served as the Hospital Epidemiologist at NewYork-Presbyterian Morgan Stanley Children’s Hospital for over two decades. Dr. Saiman is the Chair of the Department of Pediatrics’ Committee on Appointments and Promotions (CoAP) and the Associate Vice Chair for Faculty Development. Her primary research and clinical interests are hospital epidemiology and healthcare-associated infections across the spectrum of healthcare, ranging from the neonatal ICU to cystic fibrosis to pediatric long-term care with a particular focus on respiratory viruses.

Dr. Uslan has many years' experience leading several system initiatives improving value, quality, innovation, and performance excellence for UCLA Health. He is the Chief Infection Prevention Officer and Clinical Chief of Infectious Diseases and Associate Clinical Professor in the Division of Infectious Diseases, Department of Medicine.

Subject matter expertise includes performance improvement, clinical quality and safety, process change, clinical research design, physician relations and alignment, and innovation. Possess leadership skills including effective communication, collaboration, and boundary-spanning teamwork.

Dr. Uslan is a recipient of an American Heart Association National Scientist Development Grant. In 2012 he was awarded the a fellowship from University of California's Office of the President Center for Healthcare Quality and Innovation for study of a system-wide antimicrobial stewardship program. Dr. Uslan's clinical interests include bloodstream infections, surgical infections, endocarditis and other cardiovascular infections, and neurological infections.